Evidence about the safety and efficacy of secretion clearance devices is well documented and continues to grow.
To further the understanding of conditions like bronchiectasis and COPD and their treatment, RespirTech is committed to supporting and sharing scientific research on chronic respiratory conditions and the use of secretion clearance devices.
Clinical posters
Case finding COPD and comorbid non-CF bronchiectasis in rural upstate New York: Keystone to successful COPD population health management – Clinical poster presented at American Thoracic Society (ATS) 2019 Conference.
Two years of high frequency chest wall oscillation (HFCWO) outcomes in a large registry of non-CF bronchiectasis patients – Clinical poster presented at American Thoracic Society (ATS) 2019 Conference
High frequency chest wall oscillation (HFCWO) responder analysis in a large registry of non-CF bronchiectasis patients – Clinical poster presented at American Thoracic Society (ATS) 2019 Conference
Outcomes of high frequency chest wall oscillation (HFCWO) in COPD patients without bronchiectasis – Clinical poster presented at the 2019 CHEST meeting
Outcomes with High-Frequency Chest Wall Oscillation among Patients with COPD using a Large Claims Database – Clinical poster presented at the 2020 CHEST meeting
A Retrospective Real-World Cohort Study Demonstrating the Impact of HFCWO Therapy on Patients with Neuromuscular Disorders – Clinical poster presented at the 2020 CHEST meeting
RespirTech supports and shares scientific research to further understanding of chronic respiratory conditions and how they may be managed.
Real-life experience with high-frequency chest wall oscillation vest therapy in adults with non-cystic fibrosis bronchiectasis – Peer-reviewed paper published in Therapeutic Advances in Respiratory Disease, June 2019
Optimization of secretion clearance with the high frequency chest wall oscillation triangle waveform – published inRespiratory Therapy Magazine 2016 article
Adaptive high frequency chest wall oscillation (HFCWO) therapy for maximum patient adherence: A patient-centered approach – Paper published in Respiratory Therapy Magazine 2019 article
Lung Volume Recruitment: Maximize the Therapeutic Impact from Mechanical Insufflation-Exsufflation (MI-E) Devices – published in Respiratory Therapy Magazine 2020 article
RespirTech helps patients, caregivers and healthcare providers breathe easier with proven technology and the assistance of our licensed respiratory specialists.
By clicking on the link, you will be leaving the official Royal Philips Healthcare ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.